OIC is now conducting COVID-19 Treatment and Prevention studies in addition to other clinical research trials! Inquire below today!
Orlando Immunology Center (OIC) is proud to announce to the Central Florida community that our research center located at 1707 N Mills Avenue, Orlando, 32803 has been selected by the National Institutes of Health (NIH) in collaboration with the HIV Vaccine Trial Network (HVTN) to participate in one of the most promising COVID-19 vaccine studies sponsored by Oxford University and AstraZeneca.
OIC is one of 33 other sites in the country (and the only one in Florida) selected for participants study enrollment starting this summer, along with research sites in other countries. This study aims to evaluate ~30,000 subjects (about half in the US) at high risk for COVID infection, including healthcare workers, to demonstrate the vaccine efficacy in preventing COVID-19.
There are currently over 115 potential COVID-19 preventive vaccine candidates being investigated worldwide by private industry, academic centers, or non-profit organizations, most in early clinical research development. Federal experts have selected the following five companies with COVID-19 vaccine clinical trials that may have the best chances of success: Moderna; Oxford University and AstraZeneca; Johnson & Johnson; Merck; and Pfizer.
There are other potential COVID-19 vaccine candidates in more advanced stages of clinical development, but they are being developed by smaller companies, with limited experience in large-scale vaccine manufacturing, which could affect their end success.
Clinical Trial Inquiry
About Orlando Immunology Center (OIC)
OIC is an infectious Disease practice specializing in the treatment of HIV, hepatitis, and other viral illness for the last 20 years. The studies conducted at OIC have been at the vanguard of prevention and treatment for many other viral infections. “By using our relationships with private sponsor corporations that are now working hard and expeditiously to develop a successful COVID-19 vaccine, we can offer Central Floridians the opportunity to participate in this pivotal and potentially game-changer study, and to get vaccinated earlier than the average citizen” explains Dr. Edwin DeJesus, OIC Medical Director.
About AstraZeneca and the University of Oxford
AstraZeneca and the University of Oxford today announced an agreement for the global development and distribution of the University’s potential recombinant adenovirus vaccine aimed at preventing COVID-19 infection from SARS-CoV-2.
More Articles
Dr. DeJesus Recognized by Orlando Magazine
For the 5th consecutive year, Dr. DeJesus has been recognized by his peers in Orlando Magazine for his work as medical director at Orlando Immunology Center. Dr. DeJesus is a graduate from the University of Puerto Rico, School of Medicine. He completed his Internal Medicine training and Infectious Disease fellowship at the Medical College of…
Read More
Join OIC at the 2015 AIDS Walk Orlando
Orlando Immunology Center is pleased to announce that we will again be sponsoring a team at this year’s 2015 AIDS Walk Orlando. If you are interested in joining our team or donating to this worthwhile cause, please let us know. Saturday, March 28, 2015 In Florida, 15% of all new HIV infections reported among females…
Read More
OIC Wins Wave Award for Favorite Local Healthcare Professional
The Orlando Immunology Center (OIC) announced today they have received the Central Florida/Orlando 2015 Watermark Awards for Variety and Excellence (WAVE) Award for favorite local healthcare professional. “We see this as a huge honor and will continue to do everything in our power to help patients from all walks of life be healthy, happy and…
Read More
Big Gay Brunch
In conjunction with Come Out with Pride 2016, Big Gay Brunch presented by Orlando Immunology Center, will feature an amazing brunch spread, bottomless mimosas and a Bloody Mary bar, entertainment and special surprise performances. Eat, drink and come out with pride! Come join us and get your tickets today!! OUR TEAM REQUEST AN APPOINTMENT
Read More
New PrEP Study
New PrEP Study 5/19/17 UPDATE – This is an ongoing study but enrollment has closed. Orlando Immunology Center is excited to announce a new study for Pre-Exposure Prophylaxis (PrEP). Pre-Exposure Prophylaxis (PrEP) This study is to evaluate if a once daily investigational medicine can help reduce the risk of HIV infection from sex. You may qualify…
Read More
8 Tips to Help Medically Prepare For a Hurricane
Here are 8 tips to help medically prepare for a hurricane. Hurricanes can be incredibly destructive bringing lots of wind and rain over an extended period of time. Orlando Immunology Center wants to ensure that you are medically prepared in the event Central Florida finds itself in the path of one of these major storms.…
Read More
Florida HIV Needs Assessment
What is the Florida HIV Needs Assessment? The Florida HIV Needs Assessment is a survey conducted by the Florida Department of Health (DOH). The survey asks people living with HIV in Florida questions about their healthcare. It only takes about 5 minutes and is completely anonymous. It is an opportunity for People Living With HIV/AIDS (PLWHA) to share their…
Read More
2017 HIV MEDICATION GUIDE
Here is POZ Magazines 2017 HIV Medication Guide for quick reference to HIV medication options. We’ve come a long way in the treatment of HIV. Today, there are many safe and effective drugs on the market that are easy to take and have fewer side effects. It’s very important to get onto treatment as soon…
Read More
Reports: Publix Denying Employees Access to HIV Prevention PrEP
Multiple sources are claiming that Publix is denying employees access to the HIV prevention regimen PrEP (Pre-Exposure Prophylaxis). The PrEP regimen includes regular doctor visits, labs, HIV prevention education and taking 1 pill once a day. It can be up to 99% effective at preventing HIV transmission and is recommended by the Center for Disease…
Read More
Publix Reverses Course; Covers PrEP
In an unexpected but welcomed move, Publix reverses course; covers PrEP. Less than 24 hours after Representative Carlos Guillermo Smith met with Publix officials regarding their controversial decision to not cover PrEP (Pre-Exposure Prophylaxis) in their insurance, Publix is reversing course and will expand coverage to include PrEP. Publix made the announcement by responding to…
Read More
Orlando Advocates Raise HIV Awareness
Orlando advocates raise HIV awareness through a variety of new, groundbreaking projects. National Black HIV AIDS Awareness Day (NBHAAD) February 7th brings into sharp focus the importance of these pioneering approaches to address the HIV epidemic in Central Florida. NBHAAD is a national HIV testing and treatment community mobilization initiative targeted at Blacks in the…
Read More
STD Awareness Month 2018
OIC is excited to be joining with the CDC and other national organizations to be supporting STD Awareness Month 2018 with this year’s theme: Treat Me Right. The CDC created STD Awareness Month in April to raise awareness about STDs and increase education, prevention, testing and treatment in the community. STDs are at a record high across the…
Read More
Free HIV Testing During Gay Days 2018
Free HIV testing during Gay Days – make it part of your celebration! It serves as an important reminder that we can have fun and know our status. Here’s a quick breakdown for locations and times for free HIV testing during Gay Days. Doubletree Hotel – 10100 International Drive, Orlando Florida – Citrus Room A Thursday…
Read More